Clinical outcomes of patients with major bleeding after primary coronary intervention for acute ST-segment elevation myocardial infarction

Journal of Interventional Radiology

Volumn 18, Issue 11, 2009, Pages 808-811

  Zheng, Hong Chao ^a   Zhang, Qi ^a   Zhang, Rui Yan ^a   Hu, Jian ^a   Yang, Zhen Kun ^a   Zhang, Jian Sheng ^a   Shen, Wei Feng ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Acute myocardial infarction; Adverse cardiac events; Bleeding; Primary coronary intervention

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; AORTA BALLOON; ARTICLE; BLEEDING; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; RECURRENT DISEASE; REVASCULARIZATION; ST SEGMENT ELEVATION; TREATMENT OUTCOME;

EID: 74049113833     PISSN: 1008794X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zhang Q, Zhang Q, Shen J, et al. Outcomes after primary coronary intervention with drug-eluting stent implantation in diabetic patients with acute ST elevation myocardial infarction [J]. Chin Med J, 2007, 120: 1862-1867. (Pubitemid 350111057)
2. Dauerman HL, Andreou C, Perras MA, et al. Predictors of bleeding complications after rescue coronary interventions [J]. J Thromb Thrombolysis, 2000, 10: 83-88. (Pubitemid 30741872)
3. Heer T, Zeymer U, Juenger C, et al. Beneficial effects of abciximab in patients with primary percutaneous intervention for acute ST segment elevation myocardial infarction in clinical practice[J]. Heart, 2006, 92: 1484-1489. (Pubitemid 44578849)
4. Manoukian SV, Feit F, Mehran R, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial[J]. J Am Coll Cardiol, 2007, 49: 1362-1368. (Pubitemid 46476844)
5. Antman EM, Hand M, Armstrong PW, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. J Am Coll Cardiol, 2008, 51: 210-247.
6. Fuchs S, Kornowski R, Teplitsky I, et al. Major bleeding complicating contemporary primary percutaneous coronary interventions-incidence, predictors, and prognostic implications [J]. Cardiovasc Revasc Med, 2009, 10: 88-93.
7. Steinhubl SR, Kastrati A, Berger PB. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of anti-thrombotic drugs[J]. Am Heart J, 2007, 154: 3-11. (Pubitemid 46924806)
8. Kinnaird TD, Stabile E, Mintz GS, et al. Incidence, predictors and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions[J]. Am J Cardiol, 2003, 92: 930-935. (Pubitemid 37214804)
9. Moscucci M, Fox KA, Cannon CP, et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE)[J]. Eur Heart J, 2003, 24: 1815-1823. (Pubitemid 37280247)
10. Lee DS, Bhatt DL, Moliterno DJ, et al. The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients[J]. J Invasive Cardiol, 2004, 16: 46-51.
11. Blankenship JC, Hellkamp AS, Aguirre FV, et al. Vascular access site complications after percutaneous coronary intervention with abciximab in the evaluation of c7E3 for the prevention of ischemic complications (EPIC) trial[J]. Am J Cardiol, 1998, 81: 36-40.
12. Karvouni E, Katritsis DG, Ioannidis JP. Intravenous glycoprotein IIb/IIIa receptor antagonists reduce mortality after percutaneous coronary interventions[J]. J Am Coll Cardiol, 2003, 41: 26-32. (Pubitemid 36044399)
13. Yatskar L, Selzer F, Feit F, et al. Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry[J]. Catheter Cardiovasc Interv, 2007, 69: 961-966.
14. The ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (SEPRIT): a randomized, placebo-controlled trial[J]. Lancet, 2000, 356: 2037-2044.
15. Stone GW, McLaurin BT, Cox DA, et al. Bivalirudin for patients with acute coronary syndromes [J]. N Engl J Med, 2006, 355: 2203-2216. (Pubitemid 44791162)
16. Abbas AE, Brodie B, Dixon S, et al. Incidence and prognostic impact of gastrointestinal bleeding after percutaneous coronary intervention for acute myocardial infarction [J]. Am J Cardiol, 2005, 96: 173-176. (Pubitemid 40978568)
17. Sabatine MS, Morrow DA, Giugliano RP, et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes[J]. Circulation, 2005, 111: 2042-2049. (Pubitemid 40577898)
18. Ikelboom JW, Mehta SR, Anand SS, et al. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes [J]. Circulation, 2006, 114: 774-782. (Pubitemid 44268228)